Page last updated: 2024-08-20

fluocortolone and Cutaneous T-Cell Lymphoma

fluocortolone has been researched along with Cutaneous T-Cell Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coors, EA; von den Driesch, P1

Trials

1 trial(s) available for fluocortolone and Cutaneous T-Cell Lymphoma

ArticleYear
Treatment of erythrodermic cutaneous T-cell lymphoma with intermittent chlorambucil and fluocortolone therapy.
    The British journal of dermatology, 2000, Volume: 143, Issue:1

    Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Chlorambucil; Disease-Free Survival; Drug Therapy, Combination; Female; Fluocortolone; Glucocorticoids; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Pilot Projects; Pulse Therapy, Drug; Skin Neoplasms

2000